Browsing by Subject "chronic myeloid leukemia"
Now showing items 1-4 of 4
-
ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib
(Spandidos Publ Ltd, 2014-04-01)Despite the high efficacy of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) patients, some individuals develop resistance due to impaired bioavailability. It has been previously demonstrated that the ...
-
Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia
(Wiley, 2016)The bone marrow aspiration procedure is used in hematological diseases and consists of a painful, invasive procedure causing anxiety-associated symptoms. The present study assessed the effect of Citrus aurantium L. essential ...
-
Chronic myeloid leukemia following kidney transplantation
(Elsevier B.V., 2005-03-01)Immunosuppressed renal recipients are at an increased risk of developing cancer. Leukemias are less frequent than other hematopoietic tumours and development of CML after immunosuppression is rare. We describe a 37-year-old ...
-
Megakaryocytic blast crisis as a first presentation of chronic myeloid leukemia
(Blackwell Munksgaard, 2002-07-01)Acute megakaryocytic leukemia (AmegL) corresponds to 5.0-10.0% of all acute myeloid leukemias (AML). Blast crisis as the first presentation of chronic myeloid leukemia (CML) accounts for 10.0% of all cases. Objective: We ...